Hexobarbital (Portuguese Wikipedia)

Analysis of information sources in references of the Wikipedia article "Hexobarbital" in Portuguese language version.

refsWebsite

Global rank Portuguese rank

11nih.gov

4^th place

8^th place

9doi.org

2^nd place

4^th place

1drugbank.com

low place

1jst.go.jp

1,903^rd place

5,361^st place

1aspetjournals.org

6,663^rd place

6,453^rd place

1worldcat.org

5^th place

1espacenet.com

800^th place

3,230^th place

aspetjournals.org

jpet.aspetjournals.org

Furner RL, McCarthy JS, Stitzel RE, Anders MW (outubro de 1969). «Stereoselective metabolism of the enantiomers of hexobarbital». The Journal of Pharmacology and Experimental Therapeutics. 169: 153–8. PMID 5824599

doi.org

dx.doi.org

Tseilikman VE, Kozochkin DA, Manukhina EB, Downey HF, Tseilikman OB, Misharina ME, et al. (abril de 2016). «Duration of hexobarbital-induced sleep and monoamine oxidase activities in rat brain: Focus on the behavioral activity and on the free-radical oxidation». General Physiology and Biophysics. 35: 175–83. PMID 26689857. doi:10.4149/gpb_2015039
Komelkova M, Manukhina E, Downey HF, Sarapultsev A, Cherkasova O, Kotomtsev V, et al. (agosto de 2020). «Hexobarbital Sleep Test for Predicting the Susceptibility or Resistance to Experimental Posttraumatic Stress Disorder». International Journal of Molecular Sciences. 21. PMC 7460591. PMID 32824478. doi:10.3390/ijms21165900
Bornheim LM, Borys HK, Karler R (março de 1981). «Effect of cannabidiol on cytochrome P-450 and hexobarbital sleep time». Biochemical Pharmacology. 30: 503–7. PMID 7225146. doi:10.1016/0006-2952(81)90636-5
Schnell RC, Prosser TD, Miya TS (maio de 1974). «Cadmium-induced potentiation of hexobarbital sleep time in rats». Experientia. 30: 528–9. PMID 4833683. doi:10.1007/BF01926332
Takenoshita R, Toki S (dezembro de 2004). «[New aspects of hexobarbital metabolism: stereoselective metabolism, new metabolic pathway via GSH conjugation, and 3-hydroxyhexobarbital dehydrogenases]». Yakugaku Zasshi. 124: 857–71. PMID 15577260. doi:10.1248/yakushi.124.857
Endo S, Matsunaga T, Matsumoto A, Arai Y, Ohno S, El-Kabbani O, et al. (novembro de 2013). «Rabbit 3-hydroxyhexobarbital dehydrogenase is a NADPH-preferring reductase with broad substrate specificity for ketosteroids, prostaglandin D₂, and other endogenous and xenobiotic carbonyl compounds». Biochemical Pharmacology. 86: 1366–75. PMID 23994167. doi:10.1016/j.bcp.2013.08.024
Vermeulen NP, Rietveld CT, Breimer DD (abril de 1983). «Disposition of hexobarbitone in healthy man: kinetics of parent drug and metabolites following oral administration». British Journal of Clinical Pharmacology. 15: 459–64. PMC 1427803. PMID 6849782. doi:10.1111/j.1365-2125.1983.tb01530.x
Takenoshita R, Nakamura T, Toki S (agosto de 1993). «Hexobarbital metabolism: a new metabolic pathway to produce 1,5-dimethylbarbituric acid and cyclohexenone-glutathione adduct via 3'-oxohexobarbital». Xenobiotica; The Fate of Foreign Compounds in Biological Systems. 23: 925–34. PMID 8284947. doi:10.3109/00498259309059419
Timmermann G, Czeizel AE, Bánhidy F, Acs N (1 de fevereiro de 2008). «A study of the teratogenic and fetotoxic effects of large doses of barbital, hexobarbital and butobarbital used for suicide attempts by pregnant women». Toxicology and Industrial Health. 24: 109–19. PMID 18818187. doi:10.1177/0748233708089004

drugbank.com

go.drugbank.com

«Hexobarbital». go.drugbank.com. Consultado em 8 de março de 2021

espacenet.com

worldwide.espacenet.com

B.C. BOREN ; V. CHUMAKOV; L. CHUMAKOVA ;J.R. HAMMAKER; D. KARANEWSKY; R. KIMMICH; A. NONCOVICH; A. PATRON; C. PRIEST ; J. UNG ; W. ZHAO (31 de dezembro de 2015). «COMPOUNDS USEFUL AS MODULATORS OF TRPM8». worldwide.espacenet.com. Consultado em 7 de março de 2021

jst.go.jp

jstage.jst.go.jp

Takenoshita R, Toki S (dezembro de 2004). «[New aspects of hexobarbital metabolism: stereoselective metabolism, new metabolic pathway via GSH conjugation, and 3-hydroxyhexobarbital dehydrogenases]». Yakugaku Zasshi. 124: 857–71. PMID 15577260. doi:10.1248/yakushi.124.857

nih.gov

ncbi.nlm.nih.gov

Tseilikman VE, Kozochkin DA, Manukhina EB, Downey HF, Tseilikman OB, Misharina ME, et al. (abril de 2016). «Duration of hexobarbital-induced sleep and monoamine oxidase activities in rat brain: Focus on the behavioral activity and on the free-radical oxidation». General Physiology and Biophysics. 35: 175–83. PMID 26689857. doi:10.4149/gpb_2015039
Komelkova M, Manukhina E, Downey HF, Sarapultsev A, Cherkasova O, Kotomtsev V, et al. (agosto de 2020). «Hexobarbital Sleep Test for Predicting the Susceptibility or Resistance to Experimental Posttraumatic Stress Disorder». International Journal of Molecular Sciences. 21. PMC 7460591. PMID 32824478. doi:10.3390/ijms21165900
Bornheim LM, Borys HK, Karler R (março de 1981). «Effect of cannabidiol on cytochrome P-450 and hexobarbital sleep time». Biochemical Pharmacology. 30: 503–7. PMID 7225146. doi:10.1016/0006-2952(81)90636-5
Schnell RC, Prosser TD, Miya TS (maio de 1974). «Cadmium-induced potentiation of hexobarbital sleep time in rats». Experientia. 30: 528–9. PMID 4833683. doi:10.1007/BF01926332
Takenoshita R, Toki S (dezembro de 2004). «[New aspects of hexobarbital metabolism: stereoselective metabolism, new metabolic pathway via GSH conjugation, and 3-hydroxyhexobarbital dehydrogenases]». Yakugaku Zasshi. 124: 857–71. PMID 15577260. doi:10.1248/yakushi.124.857
Endo S, Matsunaga T, Matsumoto A, Arai Y, Ohno S, El-Kabbani O, et al. (novembro de 2013). «Rabbit 3-hydroxyhexobarbital dehydrogenase is a NADPH-preferring reductase with broad substrate specificity for ketosteroids, prostaglandin D₂, and other endogenous and xenobiotic carbonyl compounds». Biochemical Pharmacology. 86: 1366–75. PMID 23994167. doi:10.1016/j.bcp.2013.08.024
Furner RL, McCarthy JS, Stitzel RE, Anders MW (outubro de 1969). «Stereoselective metabolism of the enantiomers of hexobarbital». The Journal of Pharmacology and Experimental Therapeutics. 169: 153–8. PMID 5824599
Vermeulen NP, Rietveld CT, Breimer DD (abril de 1983). «Disposition of hexobarbitone in healthy man: kinetics of parent drug and metabolites following oral administration». British Journal of Clinical Pharmacology. 15: 459–64. PMC 1427803. PMID 6849782. doi:10.1111/j.1365-2125.1983.tb01530.x
Takenoshita R, Nakamura T, Toki S (agosto de 1993). «Hexobarbital metabolism: a new metabolic pathway to produce 1,5-dimethylbarbituric acid and cyclohexenone-glutathione adduct via 3'-oxohexobarbital». Xenobiotica; The Fate of Foreign Compounds in Biological Systems. 23: 925–34. PMID 8284947. doi:10.3109/00498259309059419
Timmermann G, Czeizel AE, Bánhidy F, Acs N (1 de fevereiro de 2008). «A study of the teratogenic and fetotoxic effects of large doses of barbital, hexobarbital and butobarbital used for suicide attempts by pregnant women». Toxicology and Industrial Health. 24: 109–19. PMID 18818187. doi:10.1177/0748233708089004

pubchem.ncbi.nlm.nih.gov

Pubchem. «Hexobarbital | C12H16N2O3 - PubChem». pubchem.ncbi.nlm.nih.gov. Consultado em 2 de maio de 2016

worldcat.org

VCH Publishers (2002). Ullman's encyclopedia of industrial chemistry. [S.l.]: Wiley-VCH. OCLC 50618230